HomeCompareKAJMY vs MRK

KAJMY vs MRK: Dividend Comparison 2026

KAJMY yields 2.04% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KAJMY wins by $49.66M in total portfolio value· pulled ahead in Year 2
10 years
KAJMY
KAJMY
● Live price
2.04%
Share price
$37.72
Annual div
$0.77
5Y div CAGR
97.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.71M
Annual income
$45,005,855.70
Full KAJMY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KAJMY vs MRK

📍 KAJMY pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKAJMYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KAJMY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KAJMY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KAJMY
Annual income on $10K today (after 15% tax)
$173.52/yr
After 10yr DRIP, annual income (after tax)
$38,254,977.35/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KAJMY beats the other by $38,246,648.93/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KAJMY + MRK for your $10,000?

KAJMY: 50%MRK: 50%
100% MRK50/50100% KAJMY
Portfolio after 10yr
$24.88M
Annual income
$22,507,826.92/yr
Blended yield
90.45%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KAJMY
No analyst data
Altman Z
2.5
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KAJMY buys
0
MRK buys
0
No recent congressional trades found for KAJMY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKAJMYMRK
Forward yield2.04%2.76%
Annual dividend / share$0.77$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR97.9%32.7%
Portfolio after 10y$49.71M$56.8K
Annual income after 10y$45,005,855.70$9,798.13
Total dividends collected$49.33M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KAJMY vs MRK ($10,000, DRIP)

YearKAJMY PortfolioKAJMY Income/yrMRK PortfolioMRK Income/yrGap
1$11,104$403.98$11,206$366.19$102.00MRK
2← crossover$12,711$829.67$12,650$502.35+$61.00KAJMY
3$15,357$1,756.57$14,407$694.19+$950.00KAJMY
4$20,358$3,925.23$16,585$967.82+$3.8KKAJMY
5$31,406$9,623.60$19,342$1,363.89+$12.1KKAJMY
6$61,064$27,459.30$22,913$1,947.19+$38.2KKAJMY
7$164,085$98,746.39$27,662$2,823.89+$136.4KKAJMY
8$666,328$490,757.69$34,159$4,173.35+$632.2KKAJMY
9$4,398,920$3,685,948.43$43,337$6,308.80+$4.36MKAJMY
10$49,712,700$45,005,855.70$56,776$9,798.13+$49.66MKAJMY

KAJMY vs MRK: Complete Analysis 2026

KAJMYStock

Kajima Corporation engages in civil engineering, building construction, and real estate development and other businesses worldwide. It provides procurement and construction services comprising sale and lease of construction equipment and materials, and subcontracting for various construction projects; ground improvement, foundation construction, and soil remediation; paving of roads, bridges, airports, etc., as well as manufacture and sale of paving materials; ocean port and coastal protection work, and geological surveying; calculation and preparation of construction plans; environmental and consulting work focused on water and waste; construction machinery manufacturing; repair and reinforcement work for civil engineering structures, and sale of repair materials; and integrated facility construction, and renovation services. The company also offers building management services; leasing and operational management services of real estate, and hotel management; and brokerage and appraisal services of real estate. In addition, it provides travel agency, product sales, and business services; temporary staffing and human resources placement, and events planning services; planning of construction projects, and building and equipment leasing; design, operation, and management of information communication technology infrastructure and various computer systems; collection, transportation, and processing of waste; public relations and advertising planning and production, as well as video production services; and real estate asset management and consulting, as well as buying, selling, and brokerage of beneficial interests of a trust. Further, the company offers book publishing; hotel, golf course, and ski resort services; and architectural and civil engineering design, engineering, greening landscaping, mountain forest management, and agency handling services of property, casualty, and life insurance. The company was founded in 1840 and is headquartered in Tokyo, Japan.

Full KAJMY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KAJMY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KAJMY vs SCHDKAJMY vs JEPIKAJMY vs OKAJMY vs KOKAJMY vs MAINKAJMY vs JNJKAJMY vs ABBVKAJMY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.